Mathieu Jacob

Mathieu Jacob is currently the Director of Global Labelling Strategy in Oncology Regulatory Science, Strategy & Excellence at AstraZeneca, a role they began in 2024. Mathieu has previously held positions as Associate Director of Global Labelling Strategy at AstraZeneca and worked at GSK as a Submission Associate in Regulatory Affairs. Their experience also includes various roles at Johnson & Johnson Innovative Medicine, where they advanced from Associate to Manager in Regulatory Affairs. Mathieu is pursuing a PhD in Cellular and Molecular Medicine at the University of Ottawa, alongside a degree in Regulatory Affairs from Humber College and a BSc in Human Biology with a focus on Genetics and Biotechnology from the University of Toronto.